Researching PREP in neurodegeneration

Our research group is studying the role of prolyl oligopeptidase (PREP, formerly known as POP) in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. We want to find out if PREP enzyme inhibitors are effective in preventing toxic aggregation of aggregation-prone proteins in these disorders. To put it simply, we are trying to find novel possibilities for drug therapy in neurodegenerative disorders.



Major grant for Timo from Sigrid Juselius Foundation!

Collaboration paper accepted to Neuropharmacology!

Read about our latest research news or get our latest publications

Follow us also on Facebook or Twitter (@MyohanenTimo, #preplab)

Our current supporters:

Academy of Finland Jane and Aatos Erkko Foundation
Sigrid Juselius Foundation HY__LC01_LogoFP_3L_B1___WEB